Imaging tamoxifen retinopathy using spectral-domain optical coherence tomography

Area of Science:

• Ophthalmology
• Medical Imaging
• Pharmacology

Background:

• Tamoxifen is a widely used medication for breast cancer treatment.
• Tamoxifen retinopathy is a potential ocular side effect that requires careful monitoring.
• Spectral-domain optical coherence tomography (SD-OCT) is a crucial imaging modality for retinal diagnostics.

Observation:

• This case report details the SD-OCT findings in a patient with tamoxifen retinopathy.
• Characteristic refractile deposits were observed between the ganglion cell layer and inner plexiform layer.
• A distinct defect with sharp edges was noted in the outer retinal layer, affecting the photoreceptor layer.

Findings:

• SD-OCT revealed specific patterns of retinal deposits and outer retinal disruption.
• The observed outer retinal defect showed unique characteristics, including sharp edges and photoreceptor layer involvement.
• The presence of an attached posterior hyaloid membrane suggested a pathomechanism distinct from macular holes.

Implications:

• These SD-OCT findings aid in the diagnosis and understanding of tamoxifen retinopathy.
• Differentiating tamoxifen retinopathy from other conditions like macular holes is critical for appropriate patient management.
• Further research into the specific pathomechanisms of tamoxifen retinopathy is warranted.